LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $33,000 | 0.0% | 291 | -35.6% | 0.00% | 0.0% |
| Q1 2020 | $33,000 | -28.3% | 452 | +2.5% | 0.00% | 0.0% |
| Q4 2019 | $46,000 | +206.7% | 441 | +687.5% | 0.00% | +100.0% |
| Q3 2018 | $15,000 | -93.8% | 56 | -97.2% | 0.00% | -95.7% |
| Q2 2017 | $240,000 | -38.1% | 1,973 | -48.1% | 0.02% | -43.9% |
| Q3 2016 | $388,000 | +691.8% | 3,800 | +724.3% | 0.04% | +485.7% |
| Q1 2016 | $49,000 | +96.0% | 461 | +84.4% | 0.01% | +133.3% |
| Q2 2015 | $25,000 | -32.4% | 250 | -64.3% | 0.00% | -40.0% |
| Q4 2014 | $37,000 | +32.1% | 700 | +16.7% | 0.01% | +25.0% |
| Q3 2014 | $28,000 | -93.2% | 600 | -90.9% | 0.00% | -92.6% |
| Q2 2014 | $411,000 | – | 6,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |